* Accuray Inc ARAY.OQ reported a quarterly adjusted loss
of 6
cents per share for the quarter ended in March, lower than the
same quarter last year, when the company reported EPS of 1
cents. The mean expectation of four analysts for the quarter
was for a loss of one cent per share. Wall Street expected
results to range from -3 cents tozero cents per share.
* Revenue fell 14.3% to $101.13 million from a year ago;
analysts
expected $113.65 million.
* Accuray Inc shares had fallen by 13.8% this quarter and
lost 24.7% so far this year.
FORECAST CHANGES
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is "buy."
Wall Street's median 12-month price target for Accuray Inc is
$8.00
This summary was machine generated from LSEG data May 1 at 09:02
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.01 -0.06 Missed
Dec. 31 2023 -0.05 -0.10 Missed
Sep. 30 2023 -0.05 -0.03 Beat
Jun. 30 2023 0.01 -0.03 Missed